Jess Parker Shatkin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jess Parker Shatkin has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Anna Ivanenko
Northwestern Univ, Evanston, IL 60208 USA
7 shared publications - Argelinda Baroni
New York Univ, Grossman Sch Med, New York, NY USA
5 shared publications Anna Ivanenko
4 shared publications- Reut Gruber
Department of Psychiatry, McGill University, Montreal, QC, Canada
4 shared publications - Alexander S. Young
Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, United States
3 shared publications Christina A. Di Bartolo
A Department of Child and Adolescent Psychiatry , New York University School of Medicine , New York City , New York , USA
3 shared publications
Latest Publications
- Open Access
- 19 June 2024
- Published by Frontiers Media SA in Frontiers in Sleep
- Vol. 3, 1389052
Pharmacological management of pediatric insomnia
Insomnia is the most commonly reported sleep disorder among children and adolescents, impacting their cognitive, emotional, behavioral, and physical development. The prevalence of insomnia generally increases with age, often persisting into adulthood if unaddressed. Insomnia is exceedingly common among those with developmental disabilities and is frequently comorbid with a great range of psychiatric diagnoses. The COVID-19 pandemic has only increased the prevalence of insomnia among children and adolescents. Health care providers are routinely called upon to treat insomnia in the pediatric population. Psychoeducation and behavioral interventions, especially cognitive behavioral therapy for insomnia (CBT-I), remain the first line treatments, given empirical evidence for their efficacy and success in relapse prevention. However, medications are frequently employed in clinical practice, despite the fact that no medications are approved by the Food and Drug Administration (FDA) for the treatment of pediatric insomnia. This review was designed to educate and support practitioners who are treating children and adolescents who struggle with insomnia. A thorough narrative review was completed to identify all published medication studies of pediatric insomnia; the identified studies are described and then graded into four categories according to the strength of the evidence supporting their use, side effect profiles, co-morbidities, and overall risk vs. benefit of each pharmacological treatment. This review will help practitioners in making clinical decisions for their pediatric patients who suffer with insomnia.
- 19 June 2024
- Published by Frontiers Media SA in Frontiers in Sleep
- Vol. 3, 1389052
Open AccessPharmacological management of pediatric insomnia
Insomnia is the most commonly reported sleep disorder among children and adolescents, impacting their cognitive, emotional, behavioral, and physical development. The prevalence of insomnia generally increases with age, often persisting into adulthood if unaddressed. Insomnia is exceedingly common among those with developmental disabilities and is frequently comorbid with a great range of psychiatric diagnoses. The COVID-19 pandemic has only increased the prevalence of insomnia among children and adolescents. Health care providers are routinely called upon to treat insomnia in the pediatric population. Psychoeducation and behavioral interventions, especially cognitive behavioral therapy for insomnia (CBT-I), remain the first line treatments, given empirical evidence for their efficacy and success in relapse prevention. However, medications are frequently employed in clinical practice, despite the fact that no medications are approved by the Food and Drug Administration (FDA) for the treatment of pediatric insomnia. This review was designed to educate and support practitioners who are treating children and adolescents who struggle with insomnia. A thorough narrative review was completed to identify all published medication studies of pediatric insomnia; the identified studies are described and then graded into four categories according to the strength of the evidence supporting their use, side effect profiles, co-morbidities, and overall risk vs. benefit of each pharmacological treatment. This review will help practitioners in making clinical decisions for their pediatric patients who suffer with insomnia.
- 12 October 2022
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 61 (10) , S338-S339
PARENT MANAGEMENT TRAINING WORKSHOP
- 12 October 2022
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 61 (10) , S338-S339
PARENT MANAGEMENT TRAINING WORKSHOP
- 12 October 2022
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 61 (10) , S127-S128
WHILE YOU WERE SLEEPING
- 12 October 2022
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 61 (10) , S127-S128
WHILE YOU WERE SLEEPING
- 22 February 2022
- Published by Elsevier
- p. 588-597
Sleep in college students and young adults
- 1 October 2021
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 60 (10) , S314-S315
36.4 TEACHING RESILIENCE TO ADOLESCENTS AND YOUNG ADULTS
- 1 October 2021
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 60 (10) , S314-S315
36.4 TEACHING RESILIENCE TO ADOLESCENTS AND YOUNG ADULTS
- 1 October 2020
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 59 (10) , S349-S350
COGNITIVE-BEHAVIORAL THERAPY FOR INSOMNIA
- 1 October 2020
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 59 (10) , S349-S350
COGNITIVE-BEHAVIORAL THERAPY FOR INSOMNIA
- 1 October 2020
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 59 (10) , S61
THE RHYTHMS OF WELL-BEING: TREATMENT OF INSOMNIA AND CIRCADIAN RHYTHM DISTURBANCES IN YOUTH WITH MENTAL HEALTH DISORDERS
- 1 October 2020
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 59 (10) , S61
THE RHYTHMS OF WELL-BEING: TREATMENT OF INSOMNIA AND CIRCADIAN RHYTHM DISTURBANCES IN YOUTH WITH MENTAL HEALTH DISORDERS
- 1 October 2020
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 59 (10) , S207
29.2 BOOKENDS AND NEW BEGINNINGS: AN ANALYSIS OF CHILDREN’S BOOKS ABOUT PARENTAL MENTAL ILLNESS
- 1 October 2020
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 59 (10) , S207
29.2 BOOKENDS AND NEW BEGINNINGS: AN ANALYSIS OF CHILDREN’S BOOKS ABOUT PARENTAL MENTAL ILLNESS
- 31 August 2020
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 3 (8) , e2016117
Increasing Access for the Treatment of Eating Disorders Among College Students
In recent years, psychiatry has gained a deeper understanding of the breadth of eating disorders and rightly expanded the definition to include a broad spectrum
- 31 August 2020
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 3 (8) , e2016117
Increasing Access for the Treatment of Eating Disorders Among College Students
In recent years, psychiatry has gained a deeper understanding of the breadth of eating disorders and rightly expanded the definition to include a broad spectrum
- 1 October 2019
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 58 (10) , S51-S52
36.2 SLEEP EDUCATION AND SLEEP HYGIENE
- 1 October 2019
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 58 (10) , S51-S52
36.2 SLEEP EDUCATION AND SLEEP HYGIENE